"The U.S. Food and Drug Administration today approved the Maestro Rechargeable System for certain obese adults, the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunge"...
Phendimetrazine tartrate tablets are indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class (see CLINICAL PHARMACOLOGY) should be measured against possible risk factors inherent in their use such as those described below.
DOSAGE AND ADMINISTRATION
Each single-scored, yellow, round tablet contains 35 mg phendimetrazine tartrate. Tablets are supplied in bottles of 100 (NDC 46672-138-10) and in bottles of 1000 (NDC 46672-138-11).
Each single-scored, blue, unimprinted round tablet contains 35 mg phendimetrazine tartrate. Tablets are supplied in bottles of 100 (NDC 46672-057-10) and in bottles of 1000 (NDC 46672-057-11).
Store at controlled room temperature 15°-30°C (59°-86°F).
Dispense in tight containers with child-resistant closures.
Manufactured by: Mikart, Inc., Atlanta, GA 30318. Rev. 05/96.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/20/2009
Additional Phendimetrazine Tartrate Information
Phendimetrazine Tartrate - User Reviews
Phendimetrazine Tartrate User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.